N-[4-[4-(4-methylimidazol-1-yl)-1H-imidazo[4,5-c]pyridin-2-yl]phenyl]-2-(3-pyridin-4-yl-1,2-oxazol-5-yl)acetamide;N-[4-[6-(4-methylimidazol-1-yl)-7H-purin-8-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-1H-pyrrolo[3,2-c]pyridin-2-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide

C107H83N29O8 — CID 163792501

About N-[4-[4-(4-methylimidazol-1-yl)-1H-imidazo[4,5-c]pyridin-2-yl]phenyl]-2-(3-pyridin-4-yl-1,2-oxazol-5-yl)acetamide;N-[4-[6-(4-methylimidazol-1-yl)-7H-purin-8-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-1H-pyrrolo[3,2-c]pyridin-2-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide

N-[4-[4-(4-methylimidazol-1-yl)-1H-imidazo[4,5-c]pyridin-2-yl]phenyl]-2-(3-pyridin-4-yl-1,2-oxazol-5-yl)acetamide;N-[4-[6-(4-methylimidazol-1-yl)-7H-purin-8-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-1H-pyrrolo[3,2-c]pyridin-2-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide (PubChem CID 163792501) has the molecular formula C107H83N29O8 and a molecular weight of 1903.04 g/mol. Its IUPAC name is N-[4-[4-(4-methylimidazol-1-yl)-1H-imidazo[4,5-c]pyridin-2-yl]phenyl]-2-(3-pyridin-4-yl-1,2-oxazol-5-yl)acetamide;N-[4-[6-(4-methylimidazol-1-yl)-7H-purin-8-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-1H-pyrrolo[3,2-c]pyridin-2-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide.

Molecular Properties

• Compound Name: N-[4-[4-(4-methylimidazol-1-yl)-1H-imidazo[4,5-c]pyridin-2-yl]phenyl]-2-(3-pyridin-4-yl-1,2-oxazol-5-yl)acetamide;N-[4-[6-(4-methylimidazol-1-yl)-7H-purin-8-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-1H-pyrrolo[3,2-c]pyridin-2-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide
• PubChem CID: 163792501
• Molecular Formula: C107H83N29O8
• Molecular Weight: 1903.04 g/mol
• Exact Mass: 1901.70
• IUPAC Name: N-[4-[4-(4-methylimidazol-1-yl)-1H-imidazo[4,5-c]pyridin-2-yl]phenyl]-2-(3-pyridin-4-yl-1,2-oxazol-5-yl)acetamide;N-[4-[6-(4-methylimidazol-1-yl)-7H-purin-8-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-1H-pyrrolo[3,2-c]pyridin-2-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide
• SMILES: Cc1cn(-c2nccc3[nH]c(-c4ccc(NC(=O)Cc5cc(-c6ccccc6)no5)cc4)cc23)cn1.Cc1cn(-c2nccc3[nH]c(-c4ccc(NC(=O)Cc5cc(-c6ccncc6)no5)cc4)nc23)cn1.Cc1cn(-c2ncnc3[nH]c(-c4ccc(NC(=O)Cc5cc(-c6ccccc6)no5)cc4)cc23)cn1.Cc1cn(-c2ncnc3nc(-c4ccc(NC(=O)Cc5cc(-c6ccccc6)no5)cc4)[nH]c23)cn1
• InChI: InChI=1S/C28H22N6O2.C27H21N7O2.2C26H20N8O2/c1-18-16-34(17-30-18)28-23-15-25(32-24(23)11-12-29-28)20-7-9-21(10-8-20)31-27(35)14-22-13-26(33-36-22)19-5-3-2-4-6-19;1-17-14-34(16-30-17)27-22-13-23(32-26(22)28-15-29-27)19-7-9-20(10-8-19)31-25(35)12-21-11-24(33-36-21)18-5-3-2-4-6-18;1-16-14-34(15-29-16)26-24-21(8-11-28-26)31-25(32-24)18-2-4-19(5-3-18)30-23(35)13-20-12-22(33-36-20)17-6-9-27-10-7-17;1-16-13-34(15-29-16)26-23-25(27-14-28-26)32-24(31-23)18-7-9-19(10-8-18)30-22(35)12-20-11-21(33-36-20)17-5-3-2-4-6-17/h2-13,15-17,32H,14H2,1H3,(H,31,35);2-11,13-16H,12H2,1H3,(H,31,35)(H,28,29,32);2-12,14-15H,13H2,1H3,(H,30,35)(H,31,32);2-11,13-15H,12H2,1H3,(H,30,35)(H,27,28,31,32)
• InChIKey: MYAAMDZVUDCWSD-UHFFFAOYSA-N
• XLogP: 19.22
• TPSA: 470.97 Ų
• H-Bond Donors: 8
• H-Bond Acceptors: 29
• Rotatable Bonds: 24
• Heavy Atoms: 144
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	1903.04
LogP ≤ 5	19.22
H-Bond Donors ≤ 5	8
H-Bond Acceptors ≤ 10	29

Frequently Asked Questions

What is the IUPAC name of N-[4-[4-(4-methylimidazol-1-yl)-1H-imidazo[4,5-c]pyridin-2-yl]phenyl]-2-(3-pyridin-4-yl-1,2-oxazol-5-yl)acetamide;N-[4-[6-(4-methylimidazol-1-yl)-7H-purin-8-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-1H-pyrrolo[3,2-c]pyridin-2-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide?

The IUPAC name of N-[4-[4-(4-methylimidazol-1-yl)-1H-imidazo[4,5-c]pyridin-2-yl]phenyl]-2-(3-pyridin-4-yl-1,2-oxazol-5-yl)acetamide;N-[4-[6-(4-methylimidazol-1-yl)-7H-purin-8-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-1H-pyrrolo[3,2-c]pyridin-2-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide (CID 163792501) is N-[4-[4-(4-methylimidazol-1-yl)-1H-imidazo[4,5-c]pyridin-2-yl]phenyl]-2-(3-pyridin-4-yl-1,2-oxazol-5-yl)acetamide;N-[4-[6-(4-methylimidazol-1-yl)-7H-purin-8-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-1H-pyrrolo[3,2-c]pyridin-2-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide.

What is the SMILES notation for N-[4-[4-(4-methylimidazol-1-yl)-1H-imidazo[4,5-c]pyridin-2-yl]phenyl]-2-(3-pyridin-4-yl-1,2-oxazol-5-yl)acetamide;N-[4-[6-(4-methylimidazol-1-yl)-7H-purin-8-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-1H-pyrrolo[3,2-c]pyridin-2-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide?

The canonical SMILES for N-[4-[4-(4-methylimidazol-1-yl)-1H-imidazo[4,5-c]pyridin-2-yl]phenyl]-2-(3-pyridin-4-yl-1,2-oxazol-5-yl)acetamide;N-[4-[6-(4-methylimidazol-1-yl)-7H-purin-8-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-1H-pyrrolo[3,2-c]pyridin-2-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide is Cc1cn(-c2nccc3[nH]c(-c4ccc(NC(=O)Cc5cc(-c6ccccc6)no5)cc4)cc23)cn1.Cc1cn(-c2nccc3[nH]c(-c4ccc(NC(=O)Cc5cc(-c6ccncc6)no5)cc4)nc23)cn1.Cc1cn(-c2ncnc3[nH]c(-c4ccc(NC(=O)Cc5cc(-c6ccccc6)no5)cc4)cc23)cn1.Cc1cn(-c2ncnc3nc(-c4ccc(NC(=O)Cc5cc(-c6ccccc6)no5)cc4)[nH]c23)cn1.

What is the InChIKey of N-[4-[4-(4-methylimidazol-1-yl)-1H-imidazo[4,5-c]pyridin-2-yl]phenyl]-2-(3-pyridin-4-yl-1,2-oxazol-5-yl)acetamide;N-[4-[6-(4-methylimidazol-1-yl)-7H-purin-8-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-1H-pyrrolo[3,2-c]pyridin-2-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide?

The InChIKey is MYAAMDZVUDCWSD-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H22N6O2.C27H21N7O2.2C26H20N8O2/c1-18-16-34(17-30-18)28-23-15-25(32-24(23)11-12-29-28)20-7-9-21(10-8-20)31-27(35)14-22-13-26(33-36-22)19-5-3-2-4-6-19;1-17-14-34(16-30-17)27-22-13-23(32-26(22)28-15-29-27)19-7-9-20(10-8-19)31-25(35)12-21-11-24(33-36-21)18-5-3-2-4-6-18;1-16-14-34(15-29-16)26-24-21(8-11-28-26)31-25(32-24)18-2-4-19(5-3-18)30-23(35)13-20-12-22(33-36-20)17-6-9-27-10-7-17;1-16-13-34(15-29-16)26-23-25(27-14-28-26)32-24(31-23)18-7-9-19(10-8-18)30-22(35)12-20-11-21(33-36-20)17-5-3-2-4-6-17/h2-13,15-17,32H,14H2,1H3,(H,31,35);2-11,13-16H,12H2,1H3,(H,31,35)(H,28,29,32);2-12,14-15H,13H2,1H3,(H,30,35)(H,31,32);2-11,13-15H,12H2,1H3,(H,30,35)(H,27,28,31,32).

What are the key properties of N-[4-[4-(4-methylimidazol-1-yl)-1H-imidazo[4,5-c]pyridin-2-yl]phenyl]-2-(3-pyridin-4-yl-1,2-oxazol-5-yl)acetamide;N-[4-[6-(4-methylimidazol-1-yl)-7H-purin-8-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-1H-pyrrolo[3,2-c]pyridin-2-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide?

N-[4-[4-(4-methylimidazol-1-yl)-1H-imidazo[4,5-c]pyridin-2-yl]phenyl]-2-(3-pyridin-4-yl-1,2-oxazol-5-yl)acetamide;N-[4-[6-(4-methylimidazol-1-yl)-7H-purin-8-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-1H-pyrrolo[3,2-c]pyridin-2-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide has a molecular weight of 1903.04 g/mol, XLogP of 19.22, 24 rotatable bonds, 8 hydrogen bond donors, and 29 hydrogen bond acceptors.

Where does this data come from?

All data for N-[4-[4-(4-methylimidazol-1-yl)-1H-imidazo[4,5-c]pyridin-2-yl]phenyl]-2-(3-pyridin-4-yl-1,2-oxazol-5-yl)acetamide;N-[4-[6-(4-methylimidazol-1-yl)-7H-purin-8-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-1H-pyrrolo[3,2-c]pyridin-2-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide;N-[4-[4-(4-methylimidazol-1-yl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-2-(3-phenyl-1,2-oxazol-5-yl)acetamide is sourced from PubChem (CID 163792501), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).